Industry Newsroom

Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI

avatar

Written by: CDO Magazine Bureau

Updated 7:14 PM UTC, Tue November 5, 2024

post detail image

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok

(US and Canada) Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise today announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI.

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in global regulatory process management and securing and renewing government approvals for healthcare interventions with Quantiphi’s expertise in AI-managed processes and documents.

“As the life sciences industry grapples with the ever-evolving regulation landscape, Quantiphi and DDReg have come together to help deliver cutting-edge solutions that streamline regulatory processes across both the drug development and commercialization lifecycle, ultimately helping improve more lives,” Marhok said. “Leveraging cloud, data and AI technologies, our joint efforts aim to accelerate approvals, enhance compliance and optimize Life Cycle Management (LCM), ensuring a faster and more efficient path to market.”

DDReg Managing Director Neeti Pant said “Our collaboration harnesses DDReg’s unparalleled regulatory knowledge and Quantiphi’s innovative technology, along with a deep understanding of artificial intelligence to revolutionize regulatory processes. Together, we are transforming how the life sciences sector navigates some of its most pressing regulatory challenges, ensuring compliance, enhancing safety and accelerating the time to market for new therapies. This collaboration will not only address current regulatory demands but also anticipate future needs, providing a framework for sustainable growth and innovation. By combining our strengths, we are paving the way for a more streamlined, effective, proactive and cost-efficient approach to regulatory affairs in the life sciences industry.”

Related Stories

July 16, 2025  |  In Person

Boston Leadership Dinner

Glass House

Similar Topics
AI News Bureau
Data Management
Diversity
Testimonials
background image
Community Network

Join Our Community

starStay updated on the latest trends

starGain inspiration from like-minded peers

starBuild lasting connections with global leaders

logo
Social media icon
Social media icon
Social media icon
Social media icon
About